Literature DB >> 8799574

Nitric oxide inhibition of basal and neurogenic mucus secretion in ferret trachea in vitro.

S I Ramnarine1, A M Khawaja, P J Barnes, D F Rogers.   

Abstract

1. In order to examine the role of nitric oxide (NO) on airway mucus secretion we studied the effects of the nitric oxide synthase (NOS) inhibitor L-N(G)-monomethyl-L-arginine (L-NMMA), a novel nitric oxide donor, (+/-)-(E)-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexeneamide (FK409), and the NO precursor L-arginine on basal mucus secretion in the ferret trachea in vitro in Ussing chambers. We also determined the effects of these agents upon secretion induced by electrical stimulation of nerves or by acetylcholine (ACh). We used 35SO4 as a mucus marker. 2. L-NMMA (0.01-1 mM) increased basal output of 35SO4-labelled macromolecules with a maximal increase above baseline of 248% at 0.1 mM L-NMMA. L-Arginine (1 mM) alone had no significant effect on basal secretion but reversed the potentiating effect of L-NMMA on basal secretion. L-NMMA-induced increases in basal mucus secretion were sustained for at least 30 min in the continuing presence of the NOS inhibitor. In contrast to the potentiating effects of L-NMMA, FK409 (100 nM) reduced basal secretion by 60% (at 1 nM and at 10 nM it was without effect). 3. Electrical stimulation (50 V, 10 Hz, 0.5 ms for 5 min) increased 35SO4 output by 174%. L-NMMA (1 and 10 mM) present during stimulation of tracheal segments resulted in significant potentiations of 214% and 116%, respectively, of the neurogenic response. The potentiated response to 10 mM L-NMMA was reversed by L-arginine (1 mM). At this dose L-arginine had no effect itself on basal secretion. In contrast to the potentiating effects of L-NMMA on neurogenic secretion, FK409 at 10 nM and 100 nM inhibited the neurogenic response by 98% and 99%. 4. At all concentrations tested, neither L-NMMA (0.01 mM-1 mM) nor FK409 (1-100 mM) had any significant effect on ACh-induced mucus secretion. 5. These observations lead us to conclude that nitric oxide, derived from constitutive NO synthase, acts as an endogenous inhibitor of both basal and neurogenic mucus secretion in ferret trachea in vitro.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8799574      PMCID: PMC1909519          DOI: 10.1111/j.1476-5381.1996.tb15498.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  Tachykinin control of ferret airways: mucus secretion, bronchoconstriction and receptor mapping.

Authors:  S Meini; J C Mak; J A Rohde; D F Rogers
Journal:  Neuropeptides       Date:  1993-02       Impact factor: 3.286

Review 2.  Non-adrenergic, non-cholinergic neural control of mucus secretion in the airways.

Authors:  S I Ramnarine; D F Rogers
Journal:  Pulm Pharmacol       Date:  1994-02

Review 3.  Nitric oxide and lung disease.

Authors:  P J Barnes; M G Belvisi
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

4.  Colocalization of vasoactive intestinal peptide and nitric oxide synthase in neurons of the ferret trachea.

Authors:  R D Dey; B Mayer; S I Said
Journal:  Neuroscience       Date:  1993-06       Impact factor: 3.590

5.  Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409.

Authors:  Y Kita; Y Hirasawa; K Maeda; M Nishio; K Yoshida
Journal:  Eur J Pharmacol       Date:  1994-05-12       Impact factor: 4.432

6.  Mucosal nitric oxide may tonically suppress airways plasma exudation.

Authors:  J S Erjefält; I Erjefält; F Sundler; C G Persson
Journal:  Am J Respir Crit Care Med       Date:  1994-07       Impact factor: 21.405

7.  Stimulation by carbachol of mucus gel thickness in rat stomach involves nitric oxide.

Authors:  K J Price; P J Hanson; B J Whittle
Journal:  Eur J Pharmacol       Date:  1994-09-22       Impact factor: 4.432

8.  Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections.

Authors:  S A Kharitonov; D Yates; P J Barnes
Journal:  Eur Respir J       Date:  1995-02       Impact factor: 16.671

9.  'Sensory-efferent' neural control of mucus secretion: characterization using tachykinin receptor antagonists in ferret trachea in vitro.

Authors:  S I Ramnarine; Y Hirayama; P J Barnes; D F Rogers
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

10.  Increased nitric oxide in exhaled air of asthmatic patients.

Authors:  S A Kharitonov; D Yates; R A Robbins; R Logan-Sinclair; E A Shinebourne; P J Barnes
Journal:  Lancet       Date:  1994-01-15       Impact factor: 79.321

View more
  6 in total

1.  Effect of vasoactive intestinal peptide (VIP)-related peptides on cholinergic neurogenic and direct mucus secretion in ferret trachea in vitro.

Authors:  Y C Liu; A M Khawaja; D F Rogers
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Neuroregulation by vasoactive intestinal peptide (VIP) of mucus secretion in ferret trachea: activation of BK(Ca) channels and inhibition of neurotransmitter release.

Authors:  Y C Liu; H J Patel; A M Khawaja; M G Belvisi; D F Rogers
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 3.  Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications.

Authors:  G W Rodway; J Choi; L A Hoffman; J M Sethi
Journal:  Chron Respir Dis       Date:  2009       Impact factor: 2.444

4.  Intravenous superoxide dismutase as a protective agent to prevent impairment of lung function induced by high tidal volume ventilation.

Authors:  Nan-Chun Wu; Fan-Ting Liao; Hao-Min Cheng; Shih-Hsien Sung; Yu-Chun Yang; Jiun-Jr Wang
Journal:  BMC Pulm Med       Date:  2017-07-26       Impact factor: 3.317

5.  Rhubarb-Evoke Mucus Secretion through Aggregation and Degranulation of Mast Cell in the Colon of Rat: In vivo and ex vivo studies.

Authors:  Di Wu; Xiaowei Xue; Chenchen Gao; Yuehong Liu; Tiantian Wang; Lisheng Li; Xuehong Tong; Feng Li; Jingdong Xu
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

6.  Nitric oxide induces MUC5AC mucin in respiratory epithelial cells through PKC and ERK dependent pathways.

Authors:  Jeong Sup Song; Chun Mi Kang; Moon Bin Yoo; Seung Joon Kim; Hyung Kyu Yoon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Sung Hak Park
Journal:  Respir Res       Date:  2007-03-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.